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 West Nile virus (WNV) is a small enveloped 
single-stranded positive sense RNA-containing 
virus with a genome of   11 Kb that belongs to 
the family  fl aviviridae ( Lindenbach and Rice, 
2001 ). WNV is a typical arbovirus, cycling be-
tween its two natural hosts, mosquitoes and 
birds ( Hayes, 2001 ). Mosquitoes transmit WNV 
to a wide range of other species (including hu-
mans), which cannot further spread the infec-
tion (dead-end hosts) but which, nevertheless, 
can exhibit signifi cant morbidity and mortality. 
Since 1999, this virus has been responsible for 
>23,000 clinically registered human infections, 
leading to nearly 1,000 deaths in the United 
States alone (http://www.cdc.gov/ncidod/
dvbid/westnile/surv&control.htm). Moreover, 
annual outbreaks in the United States have 
been registered in every year since 2000 and 
were marked by increased mortality rate in in-
fected birds ( Anderson et al., 1999 ) and horses 
( Ng et al., 2003 ) and by an increase in the fre-
quency and clinical severity of WNV infection 
within the human population ( Petersen and 
Marfi n, 2002 ). These observations are consis-
tent with fi ndings elsewhere in the world since 
the mid 1990s ( Tsai et al., 1998 ;  Chowers et al., 
2001 ;  Platonov et al., 2001 ) and suggest that the 
US strains of WNV may exhibit an increase in 
virulence compared with the original old-world 
strains of WNV. 
 The incidence of WNV infection is fairly 
uniform with age ( Mostashari et al., 2001 ) and, in 
most immunocompetent humans, the disease is 
asymptomatic ( Weiss et al., 2001 ;  Petersen and 
Marfi n, 2002 ). However, severe WNV disease, 
which includes the involvement of the nervous 
system (meningitis and encephalitis), is a disease 
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 West Nile virus (WNV) infection causes a life-threatening meningoencephalitis that be-
comes increasingly more prevalent over the age of 50 and is 40–50× more prevalent in 
people over the age of 70, compared with adults under the age of 40. In a mouse model of 
age-related vulnerability to WNV, we demonstrate that death correlates with increased 
viral titers in the brain and that this loss of virus control with age was the result of defects 
in the CD4 and CD8 T cell response against WNV. Specifi c age-related defects in T cell 
responses against dominant WNV epitopes were detected at the level of cytokine and lytic 
granule production, each of which are essential for resistance against WNV, and in the 
ability to generate multifunctional anti-WNV effector T cells, which are believed to be 
critical for robust antiviral immunity. In contrast, at the peak of the response, old and adult 
T cells exhibited superimposable peptide sensitivity. Most importantly, although the adult 
CD4 or CD8 T cells readily protected immunodefi cient mice upon adoptive transfer, old T 
cells of either subset were unable to provide WNV-specifi c protection. Consistent with a 
profound qualitative and quantitative defect in T cell immunity, old brains contained at 
least 12× fewer total effector CD8 T cells compared with adult mice at the peak of brain 
infection. These fi ndings identify potential targets for immunomodulation and treatment to 
combat lethal WNV infection in the elderly. 
© 2009 Brien et al. This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the fi rst six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
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 In principle, this age-related susceptibility could be the 
result of a generalized inability of old mice to control the 
virus at the level of both the innate and adaptive immune 
systems, of the generalized inability to control the virus by 
one of these two components, or of their focused inability to 
control the virus in selected target organs. To investigate this 
issue, infectious viral titer was determined in diff erent organs 
of adult and old mice and at diff erent time points after infec-
tion. After infection with a viral dose that kills most old but 
not adult mice, we found no signifi cant diff erence in viral ti-
ters between adult and old mice between days 2 and 5 ( Fig. 1 B 
and  Fig. S2 ). Likewise, early time points showed no diff er-
ence in spleen viral titers (Fig. S2), and our survey of other 
organs (kidney, gut and liver) also failed to show viral titer 
diff erences between old and adult animals between days 3 
and 10. We could not detect WNV in the blood past day 5 
or in any other organs past day 10, and certain organs (lung 
and skin, except the site of injection) were negative through-
out the course of infection, with the exception of the central 
nervous system. Indeed, we found signifi cantly higher viral 
titers in the brains of old mice compared with the adult coun-
terparts on days 8 and 10 after infection (actually between 
days 7 and 12 [not depicted];  Fig. 1 C , left and middle). Two 
additional lines of evidence showed that viral titers within the 
brain directly correlated to mortality. First, once the animals 
became moribund, they exhibited equivalent and high brain 
WNV titers regardless of age ( Fig. 1 B , right). Moreover, 
when higher infection doses of WNV, lethal to both adult 
and old mice, were used, both adult and old mice again ex-
hibited comparable and high brain viral titers (unpublished data). 
Therefore, in all subsequent experiments where we sought to 
dissect the immunological basis of vulnerability to WNV, we 
used the viral doses at which most old animals had high viral 
titers in brain and died but at which the majority of adult 
mice exhibited low brain WNV titers and survived. 
 Relative kinetics and roles of innate and adaptive immune 
responses in mediating defense against WNV infection 
 We next asked whether the diff erences mentioned in the 
previous section could be explained by age-related defects in 
innate or adaptive immunity. As a model of pronounced in-
nate immunity defect, we used IFN-   receptor (IFNAR)–
defi cient mice (IFNAR   /   ;  Müller et al., 1994 ), which are 
unable to respond to type I IFNs (IFN-I) and are known to 
be highly susceptible to numerous infections (for review see 
 Pestka et al., 2004 ), including WNV ( Samuel and Diamond, 
2005 ). Rag-1   /   mice ( Mombaerts et al., 1992 ), which have 
no T and B cells as a result of the lack of the recombinase es-
sential for generation of T and B cell receptors and which are 
also susceptible to many infections, including WNV ( Engle 
and Diamond, 2003 ), were used as a model of profoundly 
defi cient adaptive immunity. Our results confi rmed that both 
of these strains are highly susceptible to WNV ( Fig. 2 A ) but 
highlighted a diff erence in the mean survival times (MSTs; 
 Fig. 2 A ). Thus, IFNAR   /   mice died rapidly after infection 
(MST, 5 d), which is consistent with the lack of innate defensive 
lethality of 10%, and a mean age at death of 78 yr ( Mostashari 
et al., 2001 ;  Murray et al., 2006 ). Persons between 50 and 59 yr 
of age exhibit a 10× higher incidence of severe WNV dis-
ease, whereas persons aged 80 yr or older exhibit a 43× 
higher incidence, compared with the adults between 20 and 
40 yr of age ( Nash et al., 2001 ;  Murray et al., 2006 ). More-
over, many patients that suff er from WNV encephalitis re-
quire more than one and, possibly, several years to fully 
recover physically, functionally, and cognitively ( Weiss et al., 
2001 ), and the overall mortality in the fi rst year after infec-
tion is signifi cantly increased compared with age-matched 
controls ( Murray et al., 2006 ). 
 Aging leads to a widespread but poorly understood state 
of immunodefi ciency, which is associated with an increased 
incidence and severity of infectious disease in the elderly 
( Gardner, 1980 ). Many facets of innate and adaptive immu-
nity have been shown to be altered by aging ( Cambier, 2005 ; 
for reviews see  Miller, 1996 ;  Pawelec et al., 1998 ;  Linton and 
Dorshkind, 2004 ), but at the present it is unclear which of 
these defects are critical to impaired immune defense. It is 
further unclear whether the critical age-related defects are 
constant or whether they vary depending on the biology of 
the encountered pathogen. It is of note that T cells have been 
shown to exhibit some of the most pronounced age-related 
defects (for reviews see  Miller, 1996 ;  Nikolich-Žugich, 2005 ), 
and reversion of T cell defects has been associated with im-
proved immune function in old rodents and monkeys ( Garcia 
and Miller, 2003 ;  Haynes et al., 2004 ,  2005 ;  Messaoudi et al., 
2006 ). However, direct mechanistic links between a decline 
in T cell function and reduced immune defense against infec-
tious diseases remain scarce. Therefore, we examined the im-
munological basis of the age-related increase in susceptibility 
to WNV, and we report in this paper that qualitative and 
quantitative impairment with age in eff ector T cell immunity 
at the site of critical aff ected tissue (the brain) leads to in-
creased susceptibility to this virus. 
 RESULTS 
 Mouse model of age-related susceptibility to WNV 
 We established a robust mouse model of the age-related suscep-
tibility to WNV. In our hands, old mice exhibited increased sus-
ceptibility to WNV regardless of the infection route (i.p. or s.c.), 
the viral isolate of WNV Ia (NY-99, 31A, or 385–99;  Table S1 , 
 Fig. 1 ; see  Figs. 2 and  5 ; and not depicted), or the mouse strain 
( Fig. 1 , C57BL/6; and see  Figs. 2 and  5 , C57BL/6; or  Fig. S1 , 
BALB/c) used, although, as expected, i.p infection produced le-
thal eff ects at a lower dose (1–20 PFU) compared with the more 
physiological s.c. infection (50–1,000 PFU). Overall, old mice 
were at least six times more susceptible to WNV as measured by 
survival rates over many viral concentrations ( Fig. 1 A and not 
depicted). At low viral doses, that diff erence was drastically re-
duced and, in some experiments, disappeared ( Fig. 1 A , Table 
S1, and not depicted), whereas at the high doses both old and 
adult animals succumbed to infection, suggesting that the viral 
dose is one of the principal determinants of selective mortality of 
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adult spleen cells, as well as the adult T cells, conferred signifi -
cant protection to RAG1   /   mice. In contrast, mice that re-
ceived old cells were aff orded weaker protection, which was 
not improved in the case of splenocytes and was signifi cant for 
transferred old T cells (P < 0.04) compared with RAG1   /   
mice receiving no cell transfer. Direct comparison between 
the protective capacity of adult and old T cells revealed signif-
icantly better protection by adult T cells (P < 0.003;  Fig. 2 B ). 
Because antigen presentation and priming are not aff ected by 
either age or by the targeted deletion of Rag-1 in the adult 
RAG1   /   mice, these results collectively strongly suggested that 
the process of aging impairs resistance to WNV at the level of 
generation of primary T cell responses. 
 Age-related differences in WNV-specifi c T cell responses 
 IgM and the virus-specifi c CD8 and CD4 T cells were all im-
plicated in aff ording protection against WNV in adult mice 
( Diamond et al., 2003 ;  Shrestha and Diamond, 2004 ;  Sitati 
and Diamond, 2006 ). Given the extensive literature on the 
decline of T cell immunity with aging and our results with 
T cell transfers, we initiated experiments to test possible defects 
in the T cell pool. We fi rst examined signs of T cell activation 
mechanisms, whereas the RAG1   /   mice died within the 
same temporal window as old and adult mice (MST, 13 d). 
Because the MST of old mice was 13–14 d, we concluded 
that innate immunity in these mice, unlike that in IFNAR   /   
animals, was capable of containing the virus and fending off  
early WNV-mediated mortality. Therefore, any putative de-
fects in innate immunity in old mice, if present, do not lead 
to early loss of viral control. To confi rm this, we examined 
functional levels of IFN-I in the serum of adult and old ani-
mals. Although the results of this test cannot be taken as fully 
conclusive because of the low sensitivity of this assay ( Fig. S3 ), 
we detected no major age-related diff erences within these 
confi nes. More importantly, any defect in innate immunity 
would have been expected to result in loss of viral control 
early after infection. However, this was not observed in any 
of the experiments designed to test early viremia and viral 
spread ( Fig. 1 and Fig. S2). 
 Because the results suggested a key role for defects in adap-
tive immunity, we directly explored this possibility by per-
forming adoptive transfers of old and adult spleen cells ( Fig. 2 B , 
left) or T cells (CD4 and CD8;  Fig. 2 B , right) into adult 
RAG1   /   mice. In this series of experiments, we found that 
 Figure 1.  Age-related susceptibility to WNV disease in old mice. (A) Survival of adult (4–6 mo old) and old (18–22 mo old) mice after challenge 
with the indicated doses of WNV 385–99 s.c. or i.p. Old mice are fi ve and six times more susceptible to WNV upon i.p. (MST, 13 d) and s.c. (MST, 14 d) in-
fection, respectively, compared with adult controls. Statistical signifi cance was evaluated by the Log-rank test (***, P < 0.0005; *, P < 0.05). Please note 
that difference between the old and adult mice disappears at the high viral challenge dose, where essentially all animals succumb to infection, and also at 
the low virus dose, where old animals appear to control the low viral loads well (left; see also  Table S1 for additional experiments with other viral isolates 
and routes). Results depict mortality ( n = 12 mice/group) and are representative of at least four experiments with similar results. (B and C) Viral titers 
within indicated tissues and organs of adult and old mice after s.c. infection (1,200 PFU/mouse) were determined by quantitative PCR (B, whole blood 
expressed in approximate PFU equivalents, based on quantitative PCR of a known WNV RNA standard) or by plaque assay (C, brain). The brains of old mice 
contained signifi cantly more virus on both day 7 and day 10 after infection. In contrast, there was no difference between brain viral levels of old and 
adult moribund mice on day 12–16. For data on day 3 blood and spleen by plaque assay, please see  Fig. S2 . Horizontal bars indicate mean values of the 
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also making the cytokine ( Fig. 3 C ). That suggested the exis-
tence of superimposed qualitative defects in immunity of old 
mice against WNV. 
 To analyze the quality of the anti-WNV response in 
depth, we examined several aspects of the response, including 
the ability to produce polyfunctional cells, the intensity of 
cytokine expression/cell, the level of activation of CD8 cells 
as measured by CD43 expression, and the ability to lyse pep-
tide-coated cells ( Fig. 4 ). By each and every measure, old 
CD8 T cells were signifi cantly inferior to the adult counter-
parts. Thus, although nearly 40% of adult CD8 cells expressed 
IFN-  , TNF, and GzB ( Fig. 4 A , 3 Fxn), only 21% of adult 
cells did so. Second, expression of each of these molecules 
per cell was signifi cantly lower in old CD8 T cells ( Fig. 4 B ). 
Third, only about half of the WNV-specifi c (Tet + ) CD8 T 
cells from old mice expressed high levels of CD43, an impor-
tant activation and function marker ( Fig. 4 C ). Finally, direct 
ex vivo cytotoxicity correlated to GzB expression and was 
using multicolor fl ow cytofl uorometric analysis. We followed 
quantitative and qualitative aspects of antigen-specifi c responses 
using peptide MHC class I tetramers, as well as the functional 
response measured by the ability to produce IFN-  , TNF, and 
granzyme B (GzB) and express CD43, a molecule involved in 
T cell activation, costimulation, and eff ector function ( Onami 
et al., 2002 ), and to perform lytic function in response to re-
cently identifi ed immunodominant WNV peptide epitopes 
that stimulate CD8 + ( Brien et al., 2007 ) and CD4 + T cells 
( Brien et al., 2008 ;  Figs. 3 and  4 ). At the peak of the response 
(days 7–8 after infection), we detected a strongly signifi cant 
reduction in both percentages and numbers of CD8 + cells 
specifi c for the immunodominant class I–restricted epitope 
NS4b 2488 by both tetramer staining ( Fig. 3 A ) and IFN-  pro-
duction after brief in vitro stimulation ( Fig. 3 B ). In addition to 
these quantitative defects, the ratio between IFN-  –producing 
and NS4b 2488 Tet 
+ cells was also signifi cantly reduced in old 
CD8 cells so that less than one-half of Ag-specifi c cells were 
 Figure 2.  Relative roles of innate and adaptive immunity and the importance of the age of T cells in resistance to WNV infection. (A) IF-
NAR   /   , RAG1   /   , and WT mice were infected with the indicated WNV doses s.c., and MST and percentage of survival were scored. WNV caused rapid 
mortality (MST, 4.5 d at 200 PFU) with a very low rate of survival in IFNAR   /   mice compared with WT controls (P < 0.0001 at 200 PFU). WNV infection 
also caused signifi cant mortality in RAG-1   /   mice compared with WT controls (P < 0.0001) but MST was similar to that of WT mice (MST, 13 d at 200 
PFU). Data were compiled from two independent experiments. (B) Adoptive transfer of lymphocytes from old and adult mice reveals age-related defects 
in adaptive immunity. Splenocytes (10 7 /animal) from adult mice protect RAG-1   /   signifi cantly better than splenocytes from old mice (top; MST, 14.5 at 
100 PFU; P = 0.0025). Transfer of purifi ed T cells (CD4 and CD8; 5 × 10 6 /mouse) reveals defects in old T cells, which were inferior at protecting RAG1   /   
mice compared with the purifi ed T cells from adult mice (bottom; 100 PFU; P < 0.03). Compared with RAG1   /   mice with no transfer, old splenocytes 
conferred no signifi cant protection, whereas old T cells showed some protection (P = 0.04). **, P = 0.01–0.001; ***, P < 0.001. Results are representative of 
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relevant for protection against WNV in vivo. To that 
eff ect, we performed two types of adoptive transfer ex-
periments using RAG1   /   mice as recipients. First, we 
transferred total T cells from WT, IFN-    /   , or perforin   /   
donors into RAG1   /   recipients, which showed that T 
cells defective in IFN-  or perforin provide negligible, if 
any, protection as compared with animals which received 
no cells at all ( Fig. 5 A ). This confi rms and extends prior 
results on the importance of these molecules in anti-WNV 
protection ( Engle and Diamond, 2003 ;  Wang et al., 2003 ) 
and stresses the critical role of their expression in T cells. 
However, because old T cells have a reduction but not a 
complete absence of these molecules, we tested their anti-
viral ability in vivo by separately transferring highly puri-
fi ed (< 0.5% cross-contamination) CD4 and CD8 T cells 
from old or adult naive donors into adult RAG1   /   recip-
ients. These results convincingly showed that either adult 
CD4 or adult CD8 T cells were suffi  cient to confer signifi -
cant protection to RAG1   /   mice against primary WNV 
infection in the absence of other components of the adap-
tive immune system ( Fig. 5 B ). More importantly, neither 
the CD4 + nor the CD8 + T cells from the old mice were 
able to confer any protection upon RAG1   /   mice over 
the level seen in the absence of transfer ( Fig. 5 B ), al-
though the combination of the two old T cell subsets did 
show some synergy, aff ording a low level of protection 
( Fig. 2 B , bottom). 
essentially nonexistent in CD8 T cells from old mice com-
pared with adult counterparts ( Fig. 4 D ). 
 These fi ndings were consistent in every experiment per-
formed. Sometimes not all the parameters would reach statis-
tical signifi cance when smaller animal groups were used, but 
at least three out of four observations were always signifi cant. 
Similarly, these trends and signifi cant diff erences were con-
fi rmed with the CD8 epitope ENV 347 and also in CD4 
+ cells 
using the immunodominant CD4 + T cell epitopes (ENV 641 
and NS3 1616+2066 ) by measuring frequency and magnitude of 
the IFN-  ( Fig. S4 ) and other responses (not depicted). Based 
on the prior descriptions of signaling defects in CD4 T cells 
( Garcia and Miller, 2003 ; for review see  Miller, 1996 ), we 
expected that some of the stated problems in old T cells may 
trace to inferior ability of old T cells to process antigenic stimu-
lus. However, experiments examining peptide sensitivity of 
WNV-specifi c CD8 and CD4 T cells showed superimposable 
sensitivity of old and adult cells at the peak of the response 
( Fig. S5 ). We conclude that old mice exhibit profound quan-
titative and qualitative defects in mobilizing fully developed 
eff ector T cells but that these defects do not extend to all as-
pects of antigen recognition and activation. 
 Mechanisms of T cell–mediated protection against WNV 
disease and their failure in old mice 
 We next wanted to determine whether the observed re-
duction in IFN-  secretion and/or GzB expression were 
 Figure 3.  Functional quantitative defects in T cell activation in response to WNV infection . Infection was as in  Fig. 1 A . (A) CD8 + T cells derived 
from spleens of old and adult mice were harvested on day 8 and analyzed for the proportion (left and middle left, representative examples; middle right, 
aggregate analysis of relative numbers) and absolute numbers (right, absolute numbers) of cells expressing the CD8 + NS4b-2488:K b+ phenotype. Dots 
denote individual mice ( n = 8) and are representative of four experiments. (B) Same as A, except that measurements show relative representation and 
absolute numbers of CD8 + IFN-  + cells in response to the immunodominant NS4b-2488 CD8 epitope by ICCS ( Brien et al., 2007 ) at the peak of the im-
mune response (day 8). Old mice mobilized signifi cantly fewer numbers of IFN-  –producing WNV-specifi c CD8 + T cells than their adult counterparts. 
Results were compiled from three independent experiments. (C) Ratio between IFN-  + and Tet + CD8 + cells shows that many fewer Ag-specifi c T cells are 
functionally able to manufacture this cytokine in the old mice. Groups, representation, and graphics are as in A, and results are representative of two 
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mice, like in the adult animals, CD3 + cells readily infi l-
trated the brain parenchyma on days 7 (not depicted) and 
12 ( Fig. 6 A ), suggesting that there was no major diff erence 
in migration and homing. In contrast, the composition of 
the infi ltrate was both qualitatively and quantitatively dif-
ferent ( Fig. 6, B and C ). The large (activated) mononuclear 
cell gate ( Fig. 6 B ) contained nearly 3× fewer cells in old 
mice compared with adult counterparts (3.1 vs. 9.1%, P < 
0.0005). Moreover, within that gate, the percentage of 
CD4 and CD8 cells was also about twofold lower with 
old age (5.6 vs. 11.4%, P < 0.013, and 14.1 vs. 24.3%, 
 Too little and too weak: insuffi cient numbers 
of ineffective effector T cells accumulate in the brains 
of WNV-infected old mice 
 If our conclusions were correct, we would expect that they 
would hold at the level of key organs targeted by WNV. 
Alternatively, it was also possible that there may be defects 
in migration and localization of virus-specifi c T cells to the 
old brain. To address this issue, we examined the localiza-
tion and composition of leukocyte infi ltrate in the brains 
of WNV-infected old and adult mice. It is of interest that 
immunohistochemical examination revealed that in old 
 Figure 4.  Quality of WNV-specifi c responses in old mice is impaired at several levels. For all panels, animals were infected with 1,000 PFU WNV 
385–99 and were analyzed on day 8, unless otherwise indicated. (A) At the peak of infection, splenic CD8 cells were stimulated with class I–restricted 
peptides and analyzed for the expression of IFN-  , TNF, and GzB, and results were plotted to denote percentages of cells exhibiting all three molecules 
(3 Fxn), two molecules (2 Fxn), or a single molecule (1 Fxn). Results depict eight animals per group and are representative of two such experiments. (B) Rela-
tive intensity of expression of IFN-  , TNF, and GzB among CD8 + cells in response to 6 h of NS4b-2488 peptide stimulation as described in Materials and 
methods. After gating on CD8 + T cells, normalized mean fl uorescent intensity (MFI) was obtained by subtracting the mean fl uorescent intensity of the 
negative cell population from that of the positive cells. Data depict fi ve adult and six old individual mice, representative of four experiments, and are 
shown as in  Fig. 1 A . (C) Expression of CD43 on WNV-specifi c CD8 cells from adult and old mice was analyzed on day 8 after infection by selective gating 
and is expressed as percentage of Tet + CD8 + cells that are CD43 + , shown for eight animals per group and representative of three such experiments. Hori-
zontal bars in B and C indicate mean values of the unpaired Student’s  t test. (D) Ex vivo cytotoxic activity of adult and old CD8 + T cells demonstrates ma-
jor age-related functional defects. Adult and old mice were infected s.c. with WNV at a dose (1,000 PFU) that caused decreased survival of old mice 
compared with adult animals. CD8 + T cells from adult mice exhibited stronger cytotoxic activity than CD8 + T cells from old mice when assayed directly ex 
vivo 7 d after infection in a 6-h standard  51 Cr-release assay. Peptide-coated NS4b 2488 (10 
  6 M) EL-4 cells were used as targets. Values for fi ve mice per 
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CD8 T cells ( Fig. 6 D ) compared with adult brains at the 
peak of infection. 
 Two important conclusions can be drawn from these re-
sults. First, migration to the site of major virus-induced tissue 
damage is not drastically aff ected in T cells of old animals. 
Second, although old T cells apparently arrived to the site of 
infection, they were not able to diff erentiate into eff ector T 
cells either systemically or locally in numbers suffi  cient to en-
sure control of neurovirulence. Therefore, our results iden-
tify defects in generation of suffi  cient number and quality of 
eff ector antiviral T cells as the key phenomenon underlying 
age-related susceptibility to WNV in this model, providing 
targets for potential therapeutic manipulation. 
P < 0.037 for CD4 and CD8 cells, respectively;  Fig. 6 C ), lead-
ing to a >5× reduction in total CD8 and CD4 cells in old 
WNV-infected brains. Among these already diminished 
numbers, the content and quality of virus-specifi c cells was 
further reduced. Therefore, the percentage of NS4b-spe-
cifi c tetramer + CD8 cells specifi c for WNV was reduced by 
another twofold (18.6 vs. 38.8%, P < 0.0012;  Fig. 6 D ), 
with another reduction in GzB-producing cells (trend but 
not signifi cant at 3.3 vs. 6.7%, P < 0.06; not depicted). 
Most importantly, when all the reductions were taken into 
account, compared with the levels found in adult mice 
(taken as 100%), our analysis suggests that old brains con-
tain at least 12.5× fewer and up to 20× fewer Tet + GzB + 
 Figure 5.  Inability of aged CD4 and CD8 T cells to protect RAG-1   /   mice against lethal WNV infection. (A) Purifi ed CD8 and CD4 T cells from 
C57BL/6 (closed squares), IFN    /   (open squares), or perforin   /   (closed triangles) mice were transferred into RAG-1   /   mice, which were then infected 
with 200 PFU WNV and scored for survival. WT T cells exhibited signifi cantly enhanced protection when compared with RAG-1   /   mice with no transfer 
(closed circles, P < 0.0006) or RAG-1   /   mice receiving perforin   /   (P < 0.003) or IFN-    /   T cells (P < 0.01). (B) Young RAG-1   /   mice received no cells 
(closed diamonds) or received highly purifi ed adult (squares) or old (inverted triangles) CD4 (closed symbols) or CD8 (open symbols) T cells (5 × 10 6 cells/
mouse). Engraftment was verifi ed after 24 h, with animals infected with 200 PFU WNV, and survival was scored thereafter. Adoptive transfer of old CD4 
or CD8 T cells failed to confer any protection to RAG-1–defi cient hosts, whereas transfer of adult CD4 (P < 0.0001) or CD8 (P < 0.01) T cells afforded a 
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 Figure 6.  Analysis of brain infi ltrates from WNV-infected adult and old mice. The brains of old and adult C57BL/6 mice were harvested 12 d after 
infection with 1,000 PFU WNV 385–99 s.c., sectioned, and costained for CD3 (green) and WNV (red). (A) Representative adult (top) and old (bottom) brains 
are shown at medium (left) and high (right) power. CD3 T cells are stained green and WNV-infected neurons are red. Bar: (left) 50 μm; (right) 20 μm. 
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vent the block in lymphopoiesis and the stromal rejuvenation 
using KGF, androgen blockade, or IL-7 treatment (for re-
views see  Linton and Dorshkind, 2004 ;  Nikolich-Žugich, 
2005 ) would appear to provide the best approach. 
 However, it will also be important to understand other, 
perhaps more subtle, potential defects in innate and adaptive 
immunity. Thus, although our results strongly suggest that 
there are no major age-related defects in early virus control by 
the innate immune system, they do not exclude the possibility 
of correction of T cell defects by providing enhanced activa-
tion of innate immunity by cytokine manipulation ( Haynes 
et al., 1999 ,  2004 ) and/or antigen presentation. Indeed, such 
approaches may provide more practical means for therapeutic 
intervention compared with T cell rejuvenation, which still re-
mains to be eff ectively customized for mass utilization. However, 
one could imagine providing key cytokines or costimulatory 
molecules in repeated rounds of antigen-driven T cell and 
B cell expansion to enhance and improve eff ector T cell gen-
eration. It is our belief that such intervention may be most ef-
fective to remedy the defects described in this paper. Overall, 
given the multitude of defects that aff ect an aging immune 
system, it seems prudent to elucidate specifi c and key defects 
aff ecting resistance to each pathogen and then rationally target 
the identifi ed defects for intervention. 
 MATERIALS AND METHODS 
 Mice.  Old (18–22 mo) and adult (4–6 mo) C57BL/6 (B6) mice were purchased 
from the National Institute of Aging breeding colony (Harlan). C57BL/6 
RAG1   /   , 129, C57BL/6 perforin   /   , and C57BL/6 IFN-    /   mice were 
purchased from The Jackson Laboratory and bred at the Oregon Health & Sci-
ence University (OHSU) West Campus vivarium. IFNAR   /   mice were a gift 
of A. Hill (OHSU, Beaverton, OR). All animals were housed and bred under 
specifi c pathogen-free conditions at OHSU and experiments conducted under 
the Institutional Animal Care and Use Committee and the Institutional Biosafety 
Committee approvals in accordance with all applicable federal, state, and local 
regulations. All WNV experiments were completed within a United States 
Department of Agriculture (USDA)–inspected Biosafety Level three facility. 
 Virus, peptides, and cell lines.  WNV strains NY99, 31A, and 385–99 
were used and all virus strains yielded similar results. WNV strains NY99 and 
385–99 were gifts of R. Tesh (University of Texas Medical Branch, Austin, 
TX). Strain 31A was provided by the USDA. Peptides NS3  1616 , NS3  2066 , 
and NS4b  2488-2496 (21st Century Biochemicals) were diluted in 10% H 2 O 
and 90% DMSO and stored at   80°C. Vero, MC57g, and EL-4 cell lines 
were mycoplasma negative and were cultured under aseptic conditions with 
DME (VERO and MC57g) or RPMI (EL-4) supplemented with antibiotics 
and 5% fetal calf serum. MC57gs were infected using an MOI of 10 for 30 h 
before use for  51 Cr assays. MC57gs were infected using an MOI of 10 for 
30 h before use for  51 Cr assays. 
 DISCUSSION 
 Our results show that specifi c age-related defects in T cell 
immunity, aff ecting both CD8 and CD4 T cells, underlie the 
susceptibility of old mice to WNV. This is in contrast to 
some of the other viral infections, such as Vaccinia, where no 
defects in GzB expression directly ex vivo can be detected 
(unpublished data), or infl uenza, where there is no reproduc-
ible age related decrease in survival in mice ( Bender et al., 
1995 ;  Gardner, 2005 ) and where the loss of CD8 T cells was 
not accompanied by impaired viral resistance ( Eichelberger et 
al., 1991 ), but it is similar to impaired lytic function of CD8 
T cells against HSV-1 in old mice ( Messaoudi et al., 2004 ). 
Numerous innate (IFN-I, complement, and innate IgM anti-
body) and adaptive (B cells and CD4 and CD8 T cells) mech-
anisms were implicated in anti-WNV resistance in adult mice 
( Diamond, 2005 ) but their relative importance and primary 
roles still remain incompletely mapped. Our results show that 
both T cell subsets play important and independent antiviral 
roles in adult mice, although there is evidence that they could 
also synergize (e.g.,  Fig. 2 ) against the virus. Adult CD4 and 
CD8 T cells were both able to secrete IFN-  (results pre-
sented in this study) and to kill infected target cells ( Brien et al., 
2007 ,  2008 ;  Purtha et al., 2007 ), which are critically impor-
tant anti-WNV eff ector mechanisms ( Shrestha et al., 2006 ; 
 Sitati and Diamond, 2006 ;  Fig. 5 A ), and both functions were 
impaired with aging ( Figs. 3 and  4 ). Moreover, adult T cells 
were polyfunctional and exhibited signifi cantly more robust 
per cell responses at the level of eff ector molecule mobiliza-
tion but did not exhibit higher TCR sensitivity ( Fig. 4 , Fig. S4, 
and Fig. S5). Of major importance are the results from adop-
tive transfers into RAG1   /   mice, where adult, but not old, 
CD4 or CD8 T cells could confer signifi cant anti-WNV pro-
tection. Because these animals possess functional (and young) 
innate and reticuloendothelial system components and only 
lack B, T, and NK-T cells, our results reveal that the defects 
in transferred aged T cells are cell autonomous in nature and 
are not precipitated by the aging of accessory and/or antigen-
presenting cells. Consistent with this fi nding, examination of 
brain T cell infi ltrates revealed normal migration in old mice 
but insuffi  cient accumulation of diff erentiated eff ector T cells, 
which were 10–20× less numerous in the brains of old mice. 
This would suggest that the use of T cell rejuvenation thera-
pies to remedy this condition may off er the best chance for 
therapeutic intervention. In this case, thymic reawakening 
and production of additional cohorts of Ag-specifi c T cells by 
the use of a combination of stem cell intervention to circum-
numbers for analysis, pools of two brains each were made and cells isolated using percoll gradient. The representation of cells using mononuclear/lymphocyte 
gate in representative adult (left) and old (middle) mice are shown. The aggregate analysis of cell percentages in this gate are shown on the right, illus-
trating that there are signifi cantly fewer cells in the lymphocyte gate in old mice. Comparison is based on at least 5 × 10 5 collected events/sample. 
(C) Representation (left) and aggregate analysis (right) of the percentage of CD4 and CD8 T cells within the brain of old versus adult mice as determined 
by fl ow cytometry. Signifi cant differences were seen in representation of these cell subsets as well. (D, left) Representation of CD8 NS4b-2488 tetramer + T 
cells among all CD8 T cells in the brains of old mice is further reduced compared with adults (P = 0.00372). (D, right) Illustration of cumulative effects of 
reduced representation of total lymphocytes, CD8 cells, and CD8 NS4b-2488 Tet + /GrB + T cells in the brains of old mice compared with adults (taken as 
100%) reveal an   12× age-related difference. Experiment is representative of three independent experiments. Horizontal bars indicate mean values of 
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 Statistical analyses.  Fisher’s exact test and Log-rank test were used to analyze 
results from survival experiments. Statistical signifi cance of viral titer observed 
between groups was analyzed using a Mann Whitney  U test. Other tests are as 
indicated. All calculations were performed using Prism software (GraphPad 
Software, Inc.). 
 Online supplemental material.  Fig. S1 shows survival of adult and old 
BALB/c mice infected with WNV. Fig. S2 shows viral titer in the organs of 
adult and old mice at indicated days after administration of a WNV dose le-
thal to old but not adult mice. Fig. S3 shows IFN-I activity in the serum of 
old and adult mice. Fig. S4 shows the response of adult and old CD4 T cells 
to class II MHC-restricted WNV peptide epitopes. Fig. S5 shows that pep-
tide sensitivity of 8-d-old and adult CD8 and CD4 T cells is largely super-
imposable. Table S1 shows that old mice exhibit increased WNV mortality 
regardless of route of injection or viral isolate. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20090222/DC1. 
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